Guardant Health (GH) announced its intention to offer $300M aggregate principal amount of convertible senior notes due 2033 in a private offering to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended. Guardant Health intends to use the net proceeds from the convertible notes offering for general corporate purposes, which may include, depending on market conditions, repurchasing a portion of Guardant Health’s 0% convertible senior notes due 2027. General corporate purposes may also include the acquisition of complementary products, technologies, intellectual property or businesses; however, Guardant Health currently does not have any agreements or commitments to complete any such transactions.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GH:
- Cathie Wood Steps Up Bet on Bullish Stock (BLSH), Trims Stake in Palantir (PLTR) amid Strong Q3 Earnings
- Guardant Health price target raised to $100 from $70 at Stifel
- Guardant Health’s Q3 2025 Earnings: Strong Growth Amid Challenges
- This Is Why Guardant Health Stock (GH) Surged 30% Today
- Guardant Health rises 31.4%